Amanote Research
Register
Sign In
MA26.09 Lazertinib, a Third Generation EGFR-TKI, in Patients With EGFR-TKI-Resistant NSCLC: Updated Results of a Phase I/Ii Study
Journal of Thoracic Oncology
- United States
doi 10.1016/j.jtho.2018.08.544
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Oncology
Respiratory Medicine
Pulmonary
Date
October 1, 2018
Authors
B.C. Cho
J. Han
S. Kim
K. Lee
D. Kim
Y. Lee
G. Lee
J. Lee
E.K. Cho
J. Kim
S.S. Lee
Y.J. Min
J. Kim
S.W. Shin
H.R. Kim
M.H. Hong
J.S. Ahn
S. Kang
S. Kim
S.B. Jang
S. Choi
M. Ahn
Publisher
Elsevier BV